Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 37

1.

Prospective evaluation of metabolic syndrome and its features in a single-center series of hematopoietic stem cell transplantation recipients.

Annaloro C, Airaghi L, Giannarelli D, Mometto G, Orsatti A, Saporiti G, Grifoni FI, Baldini M, Tagliaferri E, Vincenti D, Maira D, Onida F, Cortelezzi A.

Ann Hematol. 2018 Dec;97(12):2471-2478. doi: 10.1007/s00277-018-3452-0. Epub 2018 Jul 27.

PMID:
30054704
2.

Low-dose Synachten test with measurement of salivary cortisol in adult patients with β-thalassemia major.

Ambrogio AG, Danesi L, Baldini M, Radin R, Cassinerio E, Graziadei G, Mirra N, D'Angelo E, Marcon A, Mancarella M, Orsatti A, Bonetti F, Scacchi M, Cappellini MD, Persani L, Pecori Giraldi F.

Endocrine. 2018 May;60(2):348-354. doi: 10.1007/s12020-018-1562-z. Epub 2018 Mar 23.

3.

Thalassemic osteopathy: a new marker of bone deposition.

Baldini M, Forti S, Orsatti A, Marcon A, Ulivieri FM, Airaghi L, Zanaboni L, Cappellini MD.

Blood Cells Mol Dis. 2014 Feb-Mar;52(2-3):91-4. doi: 10.1016/j.bcmd.2013.09.008. Epub 2013 Oct 3.

PMID:
24091145
4.

Bone disease in adult patients with β-thalassaemia major: a case-control study.

Baldini M, Forti S, Orsatti A, Ulivieri FM, Airaghi L, Zanaboni L, Cappellini MD.

Intern Emerg Med. 2014 Feb;9(1):59-63. doi: 10.1007/s11739-011-0745-x. Epub 2011 Dec 17.

PMID:
22179745
5.

A comparison between metabolic syndrome post-hematopoietic stem cell transplantation and spontaneously occurring metabolic syndrome.

Airaghi L, Usardi P, Forti S, Orsatti A, Baldini M, Annaloro C, Lambertenghi Deliliers G.

J Endocrinol Invest. 2011 Jan;34(1):e6-11. doi: 10.3275/7144. Epub 2010 Jul 1.

PMID:
20595801
6.

Endocrine and bone disease in appropriately treated adult patients with beta-thalassemia major.

Baldini M, Forti S, Marcon A, Ulivieri FM, Orsatti A, Tampieri B, Airaghi L, Zanaboni L, Cappellini MD.

Ann Hematol. 2010 Dec;89(12):1207-13. doi: 10.1007/s00277-010-1007-0. Epub 2010 Jun 26.

PMID:
20582415
7.

Neuropsychological functions and metabolic aspects in subclinical hypothyroidism: the effects of L-thyroxine.

Baldini M, Colasanti A, Orsatti A, Airaghi L, Mauri MC, Cappellini MD.

Prog Neuropsychopharmacol Biol Psychiatry. 2009 Aug 1;33(5):854-9. doi: 10.1016/j.pnpbp.2009.04.009. Epub 2009 Apr 21.

PMID:
19389454
8.

Unusual association of a pituitary adenoma and a neurological emergency: case report and diagnostic steps.

Baldini M, Airaghi L, Orsatti A, Tedeschi A, Ceraldi T, Sina C, Cappellini MD.

Intern Emerg Med. 2008 Sep;3(3):297-300. doi: 10.1007/s11739-008-0135-1. Epub 2008 Feb 22. No abstract available.

PMID:
18293056
9.

Prevalence of metabolic syndrome in long-term survivors of hematopoietic stem cell transplantation.

Annaloro C, Usardi P, Airaghi L, Giunta V, Forti S, Orsatti A, Baldini M, Delle Volpe A, Lambertenghi Deliliers G.

Bone Marrow Transplant. 2008 May;41(9):797-804. doi: 10.1038/sj.bmt.1705972. Epub 2008 Jan 14.

PMID:
18195686
10.

Relationship between the sonographic appearance of the thyroid and the clinical course and autoimmune activity of Graves' disease.

Baldini M, Orsatti A, Bonfanti MT, Castagnone D, Cantalamessa L.

J Clin Ultrasound. 2005 Oct;33(8):381-5.

PMID:
16240426
11.

TNFalpha genotype affects TNFalpha release, insulin sensitivity and the severity of liver disease in HCV chronic hepatitis.

Valenti L, Pulixi E, Fracanzani AL, Dongiovanni P, Maggioni M, Orsatti A, Gianni C, Fargion S.

J Hepatol. 2005 Dec;43(6):944-50. Epub 2005 Jul 5.

PMID:
16143422
12.

Fibromyalgia symptoms after treatment for Cushing's syndrome.

Baldini M, Orsatti A, Cantalamessa L.

Clin Exp Rheumatol. 2005 Jul-Aug;23(4):552. No abstract available.

PMID:
16095132
13.

Autoimmune chronic urticaria associated with type 1 diabetes and Graves' disease.

Asero R, Orsatti A, Tedeschi A, Lorini M.

J Allergy Clin Immunol. 2005 May;115(5):1088-9. No abstract available.

PMID:
15867871
14.

A singular case of Graves' disease in congenital thyroid hemiagenesis.

Baldini M, Orsatti A, Cantalamessa L.

Horm Res. 2005;63(3):107-10. Epub 2005 Mar 17. Review.

PMID:
15775712
15.

Treatment of benign nodular goitre with mildly suppressive doses of L-thyroxine: effects on bone mineral density and on nodule size.

Baldini M, Gallazzi M, Orsatti A, Fossati S, Leonardi P, Cantalamessa L.

J Intern Med. 2002 May;251(5):407-14.

16.

Dynamics of a nosocomial outbreak of multidrug-resistant Pseudomonas aeruginosa producing the PER-1 extended-spectrum beta-lactamase.

Luzzaro F, Mantengoli E, Perilli M, Lombardi G, Orlandi V, Orsatti A, Amicosante G, Rossolini GM, Toniolo A.

J Clin Microbiol. 2001 May;39(5):1865-70.

17.

Thyroid nodules in Graves disease and the risk of thyroid carcinoma.

Cantalamessa L, Baldini M, Orsatti A, Meroni L, Amodei V, Castagnone D.

Arch Intern Med. 1999 Aug 9-23;159(15):1705-8.

PMID:
10448772
18.

Pattern of plasma cyclic nucleotides and related hormones in liver cirrhosis and hepatocellular carcinoma.

Bamonti-Catena F, Peracchi M, Conte D, Cantalamessa L, Lorenzano E, Orsatti A, Salerno F.

Clin Chem Lab Med. 1998 Sep;36(9):709-14.

PMID:
9804395
19.

Potentiating effect of galanin on GHRH-induced GH release. Comparison between old and young subjects.

Cremagnani L, Vaccari M, Maronati E, Cucchi L, Orsatti A, Lazzaroni L, Cantalamessa L.

Horm Metab Res. 1996 Feb;28(2):101-4.

PMID:
8867907
20.

The impact of long-term hemodialysis on pituitary-adrenocortical function.

Vigna L, Buccianti G, Orsatti A, Cresseri D, Bianchi ML, Cremagnani L, Cantalamessa L.

Ren Fail. 1995 Sep;17(5):629-37.

PMID:
8570877
21.

Human lymphocyte antigens in Graves' disease: correlation with persistent course of disease.

Baldini M, Pappalettera M, Lecchi L, Orsatti A, Meroni L, Tozzi R, Scalamogna M, Cantalamessa L.

Am J Med Sci. 1995 Jan;309(1):43-8.

PMID:
7825652
22.
23.

Reduction of insulin resistance after correction of nonneoplastic ovarian virilization.

Baldini M, Semprini E, Orsatti A, Viale G, Cantalamessa L.

J Endocrinol Invest. 1993 Apr;16(4):285-9.

PMID:
8514985
24.

Abnormal growth hormone responsiveness to stimuli in women with active celiac sprue.

Peracchi M, Molteni N, Cantalamessa L, Bardella MT, Peracchi G, Orsatti A, Faggioli P, Bianchi PA.

Am J Gastroenterol. 1992 May;87(5):580-3.

PMID:
1595643
25.

Inhibitory effect of somatostatin on abnormal GH response to TRH in primary hypothyroidism.

Baldini M, Catania A, Orsatti A, Manfredi MG, Motta P, Cantalamessa L.

Exp Clin Endocrinol. 1992;99(2):80-3.

PMID:
1353454
26.

Growth hormone levels in uraemic patients on haemodialysis.

Cantalamessa L, Cremagnani L, Orsatti A, Vigna L, Buccianti G.

Nephrol Dial Transplant. 1992;7(10):1068-9. No abstract available.

PMID:
1331885
27.

Effect of chronic clonidine administration on GH secretion in adult human subjects.

Catania A, Baldini M, Orsatti A, Airaghi L, Gasparini P, Cantalamessa L.

Exp Clin Endocrinol. 1991 Mar;97(1):76-80.

PMID:
1907565
28.

Increased growth hormone response to growth hormone releasing hormone induced by erythropoietin in uraemic patients.

Cantalamessa L, Cremagnani L, Orsatti A, Vigna L, Buccianti G.

Clin Endocrinol (Oxf). 1991 Jan;34(1):85-9.

PMID:
2004477
29.

CRH and lysine-vasopressin stimulation tests in the diagnosis of hypoadrenalism secondary to hypothalamic or pituitary disorders.

Cantalamessa L, Catania A, Baldini M, Orsatti A, Motta P, Peracchi G.

Horm Metab Res. 1990 Jul;22(7):389-93.

PMID:
2169450
30.

Screening for non-classic 21-hydroxylase deficiency in an HLA-B14 positive population.

Motta P, Airaghi L, Catania A, Mangone I, Orsatti A, Tenconi L, Cantalamessa L, Zanussi C.

Acta Endocrinol (Copenh). 1987 Oct;116(2):211-5.

PMID:
2821719
31.

Improvement of diabetes after treatment with somatostatin analogue SMS 201-995 in an acromegalic patient.

Cantalamessa L, Catania A, Baldini M, Orsatti A.

Horm Metab Res. 1986 Nov;18(11):790-1.

PMID:
2878866
32.

Cushing's syndrome due to unilateral adrenal nodular hyperplasia with incomplete inhibition of the contralateral gland.

Catania A, Reschini E, Orsatti A, Motta P, Airaghi L, Cantalamessa L.

Horm Res. 1986;23(1):9-15.

PMID:
3000913
33.

Circulating thyroglobulin and antithyroglobulin antibodies after fine needle aspiration of thyroid nodules.

Catania A, Cantalamessa L, Gasparini P, Mosca G, Orsatti A, Gavinelli M, Mariscotti C.

Horm Metab Res. 1985 Jan;17(1):49-50.

PMID:
3967848
34.

Evidence for differing dopaminergic activity in childhood- or adult-onset obesity.

Catania A, Cantalamessa L, Venegoni E, Orsatti A, Baldini M, Zanussi C.

Clin Endocrinol (Oxf). 1985 Jan;22(1):75-81.

PMID:
3919973
35.

Gonadotropin releasing hormone elicits abnormal hormone responses in schizophrenia.

Cantalamessa L, Catania A, Silva A, Orsatti A, Motta P, Cazzullo CL.

Psychoneuroendocrinology. 1985;10(4):481-4.

PMID:
3911248
36.

Plasma ACTH-response to the corticotropin releasing factor in patients with Cushing's disease. Comparison with the lysine-vasopressin test.

Catania A, Cantalamessa L, Orsatti A, Mosca G, Minonzio F, Motta P, Reschini E, Zanussi C.

Metabolism. 1984 May;33(5):478-81.

PMID:
6325850
37.

Gonadotropin response to gonadotropin releasing hormone in acute schizophrenia.

Cantalamessa L, Catania A, Silva A, Orsatti A, Baldini M, Mosca G, Zanussi C, Cazzullo CL.

Prog Neuropsychopharmacol Biol Psychiatry. 1984;8(3):411-7.

PMID:
6435179

Supplemental Content

Loading ...
Support Center